Search results

There are 24 search results.
April 25, 2019

Can your house keep you out of a nursing home?

We examine the impact of the accessibility of an older individual’s house on her use of nursing home care.

No title
March 15, 2019

Selection and moral hazard effects in healthcare

In the Netherlands, average healthcare expenditures of persons without a voluntary deductible are twice as high as average healthcare expenditures of persons with a voluntary deductible....

January 25, 2019

CPB-Wetenschapsprijs 2018

De CPB-Wetenschapsprijs wordt ieder jaar uitgereikt voor de CPB-studie van dat jaar met de hoogste wetenschappelijke impact.

November 30, 2018

The effect of reinsuring a deductible on pharmaceutical spending: A Dutch case study on low-income people

The basic health insurance in the Netherlands includes a mandatory deductible of currently 385 euros per adult per year. Several municipalities offer a group contract for low-income people in which the deductible is reinsured, meaning that out-of-pocket spending under the deductible is covered by supplementary insurance. This study examines to what extent such reinsurance leads to higher pharmaceutical spending.

No title
October 18, 2018

Causes of regional variation in Dutch healthcare expenditures: evidence from movers

We assess the relative importance of demand and supply factors as determinants of regional variation in healthcare expenditures in the Netherlands. Our empirical approach follows individuals who migrate between regions. We use individual data on annual healthcare expenditures for the entire Dutch population between the years 2006 and 2013.

No title
July 10, 2018

Analyse actieprogramma ‘Werken in de Zorg’

Het CPB heeft op verzoek van PVV, GroenLinks, SP, PvdA, 50PLUS, DENK, SGP en FVD het actieprogramma ‘Werken in de zorg’ geanalyseerd. Naast de budgettaire effecten komen ook de programma-effecten (het effect op de werkgelegenheid in de zorg) van het actieprogramma aan bod.

March 29, 2018

Does managed competition constrain hospitals’ contract prices? Evidence from the Netherlands

In the Dutch health care system health insurers negotiate with hospitals about the pricing of hospital products in a managed competition framework. In this paper, we study these contract prices that became for the first time publicly available in 2016. The data show substantive price variation between hospitals for the same products, and within a hospital for the same product across insurers.

December 7, 2017

Cost-Sharing Design Matters: A Comparison of the Rebate and Deductible in Healthcare

Since 2006, the Dutch population has faced two different cost-sharing schemes in health insurance for curative care: a mandatory rebate of 255 euros in 2006 and 2007, and since 2008 a mandatory deductible. Using administrative data for the entire Dutch population, we compare the effect of both cost-sharing schemes on healthcare consumption between 2006 and 2013.

October 12, 2017

Premium levels and demand response in health insurance: relative thinking and zero-price effects

In health care systems with a competitive health insurance market, governments or other sponsors (e.g. employers) often subsidize premiums to encourage enrolment. These subsidies are typically independent of plan choice leaving the absolute premium differences in place so as not to distort consumer choice of plan.

June 23, 2017

Pleidooi voor een experiment met eigen risico in de zorg

De politiek is verdeeld over het eigen risico in de zorg. Dit biedt een uitgelezen kans voor de nieuwe regering om de effecten van het eigen risico eens goed te onderzoeken. Daarvoor is een experiment nodig waarbij het eigen risico voor een gerandomiseerde groep wordt kwijtgescholden. De kabinetsformatie is een ideaal moment om hierover afspraken te maken.